TRIM9

Across TCGA pan-cancer cohorts, TRIM9 Mutation is linked to patient survival in 6 of 34 cancer types, making it a survival-associated TRIM9 data layer compared with 25 for mass-spec protein and 4 for mass-spec protein.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher TRIM9 Mutation is associated with better disease-free survival. In most high-consensus cancer types, elevated TRIM9 expression acts as an unfavorable survival marker, although some lineages such as UCEC and COAD show a favorable association.

UCEC, READ, and KIRP are the cancer types where TRIM9 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	DFS	Median	All	0.929	0.597	.004	26	view →
READ	DFS	Median	III,IV	0.182	0.745	.007	12	view →
KIRP	OS	Median	All	0.111	0.702	.001	12	view →
ESCA	OS	Median	II,III,IV	0.226	0.686	.013	12	view →
LUAD	DFS	Median	All	0.400	0.680	.036	2	view →
COAD	DFS	Median	II,III,IV	0.944	0.745	.039	1	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

TRIM9–UCEC (DFS)

Open the UCEC breakdown →